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1. Introduction 
Telomeres, the TTAGGG tandem repeats at the ends of chromosomes, become progressively 
shortened with each replication of cultured human somatic cells (reviewed in Wong and 
Collins (Wong & Collins 2003)) until a critical length is achieved, at which point the cell enters 
replicative senescence. This situation can be reversed by the enzyme named telomerase that is 
responsible for Telomere Length maintenance. Activation of the telomerase will result in 
telomere elongation and regulation of its activity can save the cell from senescence (Zvereva et 
al., 2010). Though increased activity of telomerase has been noted in cancer cell lines, telomere 
length could be in steady state suggesting alternative pathways for telomere length 
maintenance (Ouellette et al. 1999). The length of the telomere is longest at birth and decreases 
with increasing age. It has been demonstrated in cross-sectional analyses that age affects 
attrition of Telomere Length in white blood cells (Slagboom et al., 1994; Benetos et al., 2001; 
Nawrot et al., 2004). The rate of attrition is different between individuals and tissues and is 
influenced by multiple factors including oxidative stress and activity of telomerase enzyme. 
Telomere Length reflects the cumulative burden of oxidative stress and repeated cell 
replication (Serra et al., 2003), and such oxidative stress may represent the link between 
telomeres and aging-related disease in humans. Telomere shortening has been implicated as a 
mechanism explaining variations in life expectancy and aging-related diseases.  
In this chapter we will review the alterations in Telomere Length with aging and its 
association with multiple age-related diseases. We will discuss the mechanism of telomere 
shortening and how it is affected by the aging process. Finally we will review the various 
genetic components that play a part in either telomere attrition or maintenance with aging. 
2. Telomere Length and aging 
It is well established that telomere shortens with age (figure 1). Cross-sectional studies have 
demonstrated that adult telomeres become shorter with age at a relatively constant rate. As 
demonstrated in figure 1, there is an individual variation of Telomere Length change with 
age but the cumulative trend is that telomeres shorten with age. It should be pointed out 
that many of the studies evaluating the association of Telomere Length with age contain 
relatively few subjects with exceptional longevity (Frenck et al., 1998; Rufer et al., 1999; 
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Cawthon et al., 2003). Age associated attrition in telomere is linked to many age related 
diseases and their complications. This raises an important question if the link between 
Telomere Length and age related diseases are associative or causative. In the subsequent 
sections, we will review the changes associated with Telomere Length in various age related 
diseases and their progression. 
 
Fig. 1. Age-related telomere shortening in granulocytes and lymphocytes. (Hoffmann & 
Spyridopoulos 2011) 
2.1 Telomere and age associated disease 
“Chronological Aging” is a risk factor for multiple age-associated diseases (figure 2). 
However, the long and vivacious debate whether aging is a cause or effect is not settled. The 
supporters for chronological aging as a “cause” for age-related diseases put force the notion 
that age associated physiological deterioration, systems decline and immunological 
weakening resulting from the lost of natural shields, allows “chronological aging” to be an 
optimal situation for disease penetration. The opponents claim that the “physiological aging 
phenomenon” is a result of age-associated diseases. This hypothesis can be backed by the 
early onset of most of the claimed age associated diseases (i.e. Hypertension (HT), Diabetes, 
Cancer etc.) in the current western world. Can telomere pattern solve this debate? 
 
Fig. 2. Prevalence of selected chronic conditions, expressed in percentages, as a function of age 
for the US population (2002-2003 dataset). All forms of cancer and heart disease are featured. 
Source: National Center for Health Statistics, Data Warehouse on Trends in Health and Aging. 
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Telomere attrition with aging has been demonstrated in numerous studies, independent of 
the presence of any age related diseases.  This supports the notion that shortened Telomere 
Length, seen in chronologic aging may serve as a biomarker of age independent of age-
related diseases. In addition, occurrence of age-related diseases can accelerate the rate of 
telomere attrition. In fact older adults with one or more age associated diseases 
demonstrated higher attrition rate compare to healthy cohorts. Thus, aging and concurrent 
age-related diseases may play independent roles on Telomere Length; presence of both is 
synergistic in their effects on Telomere Length. 
2.1.1 Telomere and hypertension 
Hypertension is one of the most prevalent medical conditions among elderly. Almost 50% of 
the western world’s 50 years old subjects suffer from high blood pressure. The prevalence 
increases with age to about 70% in the 80 years old. Multiple factors including 
environmental and genetic background and Telomere Length have been tied to this 
increased incidence.  Though HT is more prevalent among elderly, a relationship between 
HT and Telomere Length has also been reported in the young; Jeanclos and colleagues 
(Jeanclos et al., 2000) had show that Telomere Length is shorter among younger patients 
with hypertension compared to healthy subjects at the same age. No studies have 
demonstrated a direct effect or established the mechanism by which Telomere Length affects 
blood pressure.  
2.1.2 Telomere and Cardiovascular diseases 
In addition to hypertension, age-associated Cardio Vascular Diseases (CVDs) include 
atherosclerosis, coronary artery disease, Myocardial infarction (MI), and heart failure.  
Telomere Length has been proposed as a marker for biological aging of the cardiovascular 
system.   
Telomere attrition and vascular aging 
Studies (Benetos et al., 2004; Brouilette et al., 2007; Fitzpatrick et al., 2007) have shown that 
high rate of telomere attrition is associated with elevated CVD risk.  Welleit et al. (Willeit et 
al., 2010) demonstrated higher rate of telomere shortening among people with CVD 
compared to people without CVD. In addition, Telomere Length has been established as 
independent risk predictor for myocardial infarction and stroke (figure 3). As presented in 
figure 3, while subjects among the higher tertile of Telomere Length have significantly lower 
hazard risk to develop MI, CVD, stroke and vascular death over 10 years of follow up, 
subjects in the middle or lower tertile are substantially at greater risk. Furthermore, in a 5 
years longitudinal study, those individuals with shorter telomeres were at a higher risk of 
developing coronary artery disease (CAD). Risk factors for CVD such as smoking were 
associated with telomere shortening as well (Parks et al., 2011).   
Mainous et al. (Mainous & Diaz 2010) studied the relationship between Telomere Length 
and atherosclerosis on the background of aging. He concluded that Telomere Length is 
inversely associated with arterial calcification and is highly correlated to arterial age rather 
than chronological age, supporting the notion of telomere being a yardstick for biological 
aging. Endothelial cells at the atherosclerotic plaque have been shown to have shorter 
telomeres compared to endothelial cells from subjects without CAD (Ogami et al., 2004). 
 
Reviews on Selected Topics of Telomere Biology 6 
 
Fig. 3. Cumulative hazard curves for CVD, vascular death, myocardinal infraction, and 
stroke manifesting between 1995 and 2005. (Willeit et al. 2010) 
In the first clinical observation, Samani et al. showed that severe coronary heart 
disease (CHD) is associated with shorter Telomere Length  (Samani et al., 2001). Since then, 
many studies have shown that shortened Telomere Length is linked to severity of CVD 
(Table 1), (Hoffmann & Spyridopoulos 2011); however no causal role for shortened telomere 
in etiology of CVD or its progression has been established.  
Accumulated evidence places oxidative stress as an accelerator of telomere attrition during 
cell replication (von Zglinicki 2002). Studies (Libby 2002; Stocker & Keaney 2004) denote 
inflammation and oxidative stress as the major contributors to pathophysiology of aging 
and age-related cardiovascular disease. In the Cardiovascular Health Study (CHS), in the 
face of subclinical and clinical cardiovascular disease and Telomere Length, the authors 
demonstrated negative correlation of IL-6 and C-reactive proteins with Telomere Length, 
highlighting the role of inflammation in Telomere Length regulation (Fitzpatrick et al., 
2007). O’Donovan et al. reported of increased systemic inflammation with shorter Leukocyte 
Telomere Length in the Health, Aging and Body Composition Study (Health ABC) cohort 
(O'Donovan et al., 2011). Multiple studies have shown a relationship between oxidative 
stress and short telomeres. In the West of Scotland Coronary Prevention Study (WOSCOP) 
trial by Brouilette et al. (Brouilette et al., 2007), pravastatin treatment attenuated the risk of 
coronary heart disease even though the shorter telomeres persisted, illustrating that the 
short telomere is not causatively linked to coronary artery disease. 
The review of literature unequivocally highlights the fact that the short Telomere Length is 
associated with CVD, risk factors for CVD such as hypertension and smoking and may be a 
prognostic indicator; however, no causative link between Telomere Length and CVD has 
been established. 
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Author (year)  Association with shorter Telomere Length  
Leukocyte TL  
(Cawthon et al., 2003) Cardiovascular mortality (+)  
(Brouilette et al., 2003) Premature myocardial infarction (+)  
(Benetos et al., 2004) Carotid atherosclerosis in hypertension (+)  
(Valdes et al., 2005) Smoking (+), obesity (+) in women  
(Fitzpatrick et al., 2007) Risk of myocardial infarction (+), diabetes (+)  
(Kurz et al., 2006) Degenerative aortic valve stenosis (+)  
(Brouilette et al., 2007) Occurrence of coronary heart disease (+)  
(Collerton et al., 2007) Left ventricular function in healthy 85 year olds (-)  
(van der Harst et al., 2007) Congestive heart failure (+)  
(Farzaneh-Far et al., 2008) Mortality in patients with stable coronary heart disease (+)  
(Cherkas et al., 2008) Physical activity (-)  
(De Meyer et al., 2009) Carotid plaque/intima media ratio (#)  
(Vasan et al., 2009) LV mass (-)  
(Kuznetsova et al., 2010) LV mass (-)  
(Panayiotou et al., 2010) Carotid intima-media thickness (+)  
(Atturu et al., 2010) Aortic abdominal aneurysm (+)  
(Huzen et al., 2011)  CHD (-), carotid plaques (#)  
Telomere Length in other cells  
(Wilson et al., 2008) Patients with aortic abdominal aneurysm: aortic tissue (+)  
(Spyridopoulos et al., 2008) Patients with CHD: bone marrow cells (+)  
(Spyridopoulos et al., 2009) 
Patients with CHD: CD34+ progenitor cells (+), 
granulocytes (+), monocytes (+), T-cells (+), B-cells (+)  
 
Table 1. Selected cardiovascular studies measuring Telomere Length. (adopted from 
Hoffmann & Spyridopoulos 2011), positive (+) or negative (-) association with shorter 
Telomere Length 
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2.1.3 Telomere and diabetes 
Type 2 diabetes mellitus (T2DM) is estimated to affect 438 million people globally by 2030, 
and is recognized as an epidemic in most developed countries. T2DM is a chronic metabolic 
disease resulting from a combination of genetic susceptibility, environment, behavior, and 
as yet unexplained risk factors (Saxena et al., 2007). Considerable increased prevalence and 
earlier age of onset (Ness et al., 1999; Robbins et al., 2000) have been observed in older 
people (Dewan & Wilding 2003; Selvin et al., 2006), suggesting that genetic factors may 
influence both timing and prevalence with advance age. Earlier onset of diabetes could also 
be related to the global epidemic of obesity, leading to the coining of the relatively new term 
“Diabesity” (diabetes due to obesity). Today obesity is considered a pandemic as it affects 
1.5 billion people across the world. This is a major economic and health care burden. 
However, obesity is just the beginning of cascade of physiologic events that results in a 
variety of age-associated diseases including diabetes. The relevant issues are how Leukocyte 
Telomere Length is associated with diabesity, how Telomere Length is regulated, and if 
Leukocyte Telomere Length is a coincidence, a biomarker or part of the mechanism.  
Gardner et al. (Gardner et al., 2005) reported of shorter telomeres among diabesity patients. 
In addition, they show that earlier obesity increases the risk to develop diabesity, and these 
subjects had shorter telomeres.  Thus, they put force the idea that telomere is a biomarker 
and showed negative correlation of Leukocyte Telomere Length with development of 
diabesity. Shorter Telomere Length has been observed in patients with insulin resistance, 
type 1 and type 2 diabetes mellitus. Al-Attas et al. determined the associations of Leukocyte 
Telomere Length to insulin resistance in middle-aged adult male and female Arabs with and 
without T2DM and show that Telomere Length is inversely associated with fasting insulin 
and homeostasis model assessment of insulin resistance (HOMA-IR). In this study, analysis 
revealed that HOMA-IR was the most significant predictor for Telomere Length in males. 
(Al-Attas et al., 2010).  
Multiple variables related to glycemic control including glucose, HbA1C reveal negative 
correlation with Leukocyte Telomere Length (Olivieri et al., 2009). In subjects with diabetes, 
Telomere Length is linked to the duration of diabetes; patients with more than 10 years of 
diabetes had a shorter Telomere Length compared to patients with shorter duration of 
diabetes. Moreover, Telomere Length has been established as a marker for patients’ overall 
condition; shorter leukocyte Telomere Length has been demonstrated in patients with 
diabetes complications compared to healthy control subjects. There is a positive correlation 
between telomere attrition and increased number of diabetes complications. (Fuller et al., 
1990). Using multivariate analysis including diabetes, van der Harst et al. demonstrate that 
shorter Telomere Length is associated with a higher risk for death and thus can serve as a 
predictor for death or hospitalization in patients with heart problems. (van der Harst et al., 
2010). In addition, short telomeres have been suggested by Fyhrquist et al. to be an 
independent predictor of progression of diabetic nephropathy in type 1 diabetes patients 
(Fyhrquist et al., 2010). Olivieri et al. showed that  Leukocyte Telomere Length were shorter 
in elderly patients with both T2DM and MI compared to elders with just one of them. 
Similarly, Tentolouris showed that patients with both T2DM and microalbuminuria (MA) 
have shorter telomere compared to patients with MA only, this could partly be due to the 
observation that T2DM patients have increased arterial stiffness (Tentolouris et al., 2007). 
Indeed, significant telomere shortening among T2DM patients with atherosclerotic plaques 
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has been reported compared to those without plaques (Adaikalakoteswari et al., 2007). Such 
trend between multiple risks and shorter telomere was reported in the central part of Italy 
(figure 4) (Testa et al., 2011). However, while in the study conducted by Fyhrquist et al., 
Telomere Length could serve as predictor of diabetic type 1 nephropathy progression 
(Fyhrquist et al., 2010), in a study reported by Astrup et al., Telomere Length did not differ 
between type 1 diabetic patients with or without nephropathy (Astrup et al., 2010).  
 
Fig. 4. Box plot of leukocyte Telomere Length (T/S) according to the number of diabetic 
complications. CTR -control, T2DM(–)- Diabetes only ,TSDM+N- for diabetes with 
complication. (Testa et al., 2011) 
From a mechanistic standpoint, Verzola et al. demonstrated that telomere gets shorter when 
cultivated cells were introduced to high glucose level, leading them to propose that telomere 
shortening is due to replicative senescence. Indeed, investigation of kidney with T2DM 
nephropathy displays similar effects (accelerated senescence in various renal cell types 
under high glucose levels), suggesting diabetes may boost common pathways involving 
kidney cell senescence (Verzola et al., 2008). As indicated in the section on CVD, shorter 
Leukocyte Telomere Length could also be attributed to the high oxidative stress observed in 
patients with T2D (Salpea et al., 2010). 
2.1.3.1 Telomere and diabetes: genetic perspective 
Telomere Length, like most of the quantitative traits follows a polygenic mode of inheritance 
(Falconer & Mackay 1996). The most pronounced enzyme associated with telomere is 
Telomerase (which will be discussed further on sub chapter 3) including both a protein and 
an RNA subunit encoded by TERT and TERC. Telomerase activity contributes to telomere 
elongation, while other factors including exonucleases and end replication problem 
contribute to telomere shortening. The net Telomere Length depends on both telomere 
elongation and shortening factors. However, the attempt to explore the entire cascade of 
genetic elements that affecting Telomere Length are far from completion. Here we review 
this search on the background of diabetes.  In the Women's Genome Health Study, genetic 
variation within the telomere-pathway gene loci has been associated with T2DM risk (Zee et 
al., 2011). Salpea et al. reported association of Leukocyte Telomere Length with functional 
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variant in the promoter area of uncoupling proteins 2 (UCP2) among T2DM patients 
suggesting a link between mitochondrial production of reactive oxygen species and 
Leukocyte Telomere Length (Salpea et al., 2010). Whole-genome screening with a copy 
number variation by Kudo et al. in T2DM patients revealed that loss of copy number within 
the 1.3-Mb of chromosome 4p16.3 sub-telomeric region (contains 34 putative genes)was 
associated with early-onset T2DM. (Kudo et al., 2011). 
In summary, there is mixed evidence for an association between short Telomere Length and 
diabetes, risk factors for diabetes, and complications of diabetes. Presence of more than one 
risk factor for diabetes does have a correlation with Telomere Length suggesting that it 
(Telomere Length) could be a cause rather than an effect; however, more studies are 
necessary before definitively drawing this conclusion. 
2.1.4 Telomere and Alzheimer’s disease 
Alzheimer's is a neurodegenerative disease associated with aging (Rolyan et al., 2011). 
Currently, more than 35 million people around the world are effected, and this number is 
predicted to dramaticaly increase as life expectency is prolonged. 
Memory deterioration and other cognitive domains decline are the main features of 
Alzheimer Disease (AD) which may lead to death in 3–9 years after diagnosis. Early signs of 
dementia, family history and potentially modifiable risk factors as well as biological factors 
such as Telomere Length and telomerase dysfunction can serve as early disease markers. 
(Lukens et al., 2009; Saeed et al., 2011). 
Paul presented a different view of the role of Telomere Length in age-related diseases and 
suggested that the telomere  dysfunction can be linked to certain diseases including 
Alzheimer's. In addition, he proposed that nutrients as well as epigenetic changes 
accompanied the disease progression, and can affect the telomerase activity and thus 
Telomere Length. (Paul 2011). Thomas et al. demonstrated significant differences of 
Telomere Length between Alzheimer patients and control subjects not only in the leukocytes 
but also in buccal and hippocampus cells. Interestingly enough, while the leukocyte and 
buccal cells telomere were shorter among the Alzheimer patients, in the hippocampus cells 
telomeres were longer, suggesting deferential telomere maintenance to protect the brain of 
Alzheimer's patients. (Thomas et al., 2008). Panossian et al. reported the immune system 
involvement in telomere maintenance among Alzheimer patients. However only T cell and 
B cell Telomere Length were correlated with Alzheimer's disease progression (Panossian et 
al., 2003). 
A support for the notion that Telomere Length modulates disease progression came from a 
study done by Rolyan et al.  Using aged telomerase knockout mice (G3Terc-/-), they show 
loss of neuron and impaired short-term memory in carriers of short telomere. Conversely, 
opposite effects were demonstrated in mouse model for Alzheimer's disease, both for 
memory decline as well as restoration of amyloid plaque, suggesting beneficial effects of 
telomere shortening with Alzheimer (Rolyan et al., 2011). 
In contrast, Lukens et al. did not find any association between Alzheimer progression and 
cerebellum Telomere Length (figure 5) (Lukens et al., 2009). Similar results have been 
reported by Zekry at al. in a longitudinal study among large oldest old cohorts. After two 
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years of follow-up, Alzheimer patients did not present significant shorter telomere 
compared to either demented or normal cognition groups (Zekry et al., 2010). Lof-Ohlin et 
al. compared Vascular demented patients versus Alzheimer patients and did not find any 
Telomere Length differences between the groups in such a way that it can serve as a 
predictor for either form of dementia (Lof-Ohlin et al., 2008). Though the exact association 
between Telomere Length and neurodegenerative diseases is inconclusive, there is evidence 
to suggest that “local”  Telomere Length could be more relevant and a better index than  
Leukocyte Telomere Length. 
 
Fig. 5. Relationships between age of AD onset and cerebellar T/S ratio (n = 30, solid circles 
and solid line; P = 0.027) and peripheral blood leukocyte (PBL) T/S ratio (n = 29, open 
squares and dotted line; P = 0.108). (Lukens et al., 2009) 
2.1.5 Telomere Length and cognition 
Advances in technology and medical treatment increase the life expectancy substantially 
across the world, thus more people are living to their old age. One consequence of such 
trend is that number of people with dementia that are not much prevalent at young age is 
increasing (Matthews et al., 2009). 
Cellular aging (senescence) is associated with telomere shortening but little is known about 
how it can affect dementia among the elderly. Harris et al. tested the hypothesis that 
telomere attrition with age can affect cognition changes, among the Lothian Birth Cohort 
1921. Follow adjustment for multiple covariates including childhood IQ, they reported of an 
insignificance association (Harris et al., 2006). Harris et al. also checked whether Telomere 
Length can serve as a biomarker for cognitive function in 1000 elderly Scots from the 
Lothian Birth Cohort of 1936 and found significant evidence only with higher general 
cognitive ability scores (Harris et al., 2010). In the Leiden 85 plus study, Martin-Ruiz et al. 
reported the lack for association between Leukocyte Telomere Length and mini–mental state 
examination (MMSE) , and they demoted this observation to telomere instability in this 
highly frail population (Martin-Ruiz et al., 2005). Similar results have been obtained in the 
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Nurses' Health Study (NHS) of 2000 elderly subjects (Devore et al., 2011) as well as study 
preformed in two narrow age-range cohort of the Canberra-Queanbeyan region of Australia 
(Mather et al., 2010), suggesting that Telomere Length could not serve as predictor for 
memory decline.  
In contrast, Valdes et al. reported association between sub sets of cognitive measurements 
and Leukocyte Telomere Length in the UK twin cohort study, suggesting Leukocyte 
Telomere Length as a potential biomarker of cognitive dysfunction with age (Valdes et al., 
2010). Supporting such observation, Yaffe et al. have demonstrated that subject with better 
baseline Digit Symbol Substitution Test (DSST) scored have longer telomere in the Health 
ABC study (Yaffe et al., 2011). Canela et al. have used FISH to assess Telomere Length and 
found a significant correlation between telomere attrition and cognitive decline but only in 
subjects 60–69 years of age (Canela et al., 2007). Although brain aging research has 
progressed in the last decade, it is still poorly understood. The majority of the cognitive 
deficits are still attributable to either age associated senescence or AD (Gress 2001) and not 
Telomere Length. 
2.2 Telomere and frailty 
The prevalence of severe disability among older Americans is estimated to be as much as 37 
percent (http://www.aoa.gov/PROF/Statistics/profile/2007/16.aspx.).  This number is 
predicted to grow given the increased life expectancy and rise in conditions such as obesity 
(Manton 2008). Seniors with mobility disability experience worse quality of life than those 
without activity limitations with more falls, and more days of pain (CDC 1998; Ganz et al., 
2005). They are more likely to be isolated from the community, suffer more morbidity and 
have higher incidence of mortality (Hirvensalo et al., 2000; Simonsick et al., 2001; Newman 
et al., 2003; Newman et al., 2006).  
 Frailty at a clinical level encompasses various chronic diseases associated with aging and 
therefore has been suggested to serve as a measure for biological ageing. Accumulated 
reports propose Telomere Length as an ageing biomarker. To test the theory that Telomere 
Length can serve as a biological marker for frailty, Woo et al. longitudinally studied healthy 
population using "frailty index" (figure 6) (Woo et al., 2008), and found no significant 
association between frailty index and telomere attrition either in whole group or after 
dichotomization for sex (Woo et al., 2008). 
Various explanations have been proposed for the relationship between frailty and Telomere 
Length, Waltson suggested in his review that underlying molecular changes such as 
telomere shortening and reduced telomerase activity make the older humans more 
susceptible to frailty (Walston 2004). Sharpless and DePinho associated the lack of 
rejuvenate stem cells due to telomere shortening an unwanted consequence which may 
induce aging phenotype such as frailty (Sharpless & DePinho 2007). Kirkwood suggested 
"Evolutionary theory" supported by empirical evidence that accumulation of cell and tissue 
damage with age will result in frailty. Cell damage could be part of processes such as DNA 
damage or oxidative stress and the cures lie in system maintenance or natural biological 
processes that either fix the damage or substantially slow it down. Such examples to support 
this theory for better maintenance can be seen in some of the observed differences between 
long and short live species (Kirkwood 2002). 
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Fig. 6. Frailty index and Telomere Length (a) male and (b) female (Woo et al., 2008). 
2.3 Telomere and bone structure 
Aging accelerates osteoporosis and other bone diseases. More so, since the bone loses its 
flexibility with age, they become less sensitive to any treatment (Kepler et al., 2011). 
However, there are conflicting reports in the literature regarding the exact association of 
telomere shortening and age-related bone loss, pobably due to the different phenotypes that 
have been assessed. Sanders and collgue reported a lack of association between Telomere 
Length and Bone Mineral Density (BMD), osteoporosis, or fracture in older cohort in the 
Health ABC study (Sanders et al., 2009). In elder Chinese, similar observation has been seen 
with baseline BMD or bone loss over a 4-year period and Telomere Length (Table 2) (Tang et 
al., 2010). 
 
Age (M/F) 
TL1 vs. TL3 
 (OR (95% CI)) 
TL2 vs. TL3 
(OR (95% CI)) 
p-Value 
(TL1 vs. TL3) (TL2 vs. TL3) 
65-69 (963/904) 
0.3 (0.06–1.52)/0.8 (0.36–
1.81) 
0.1 (0.01–1.29)/0.6 (0.26–
1.44) 
0.15/0.60 0.08/0.26 
70-74 (963/904) 
2.6 (0.47–14.21)/1.1 
(0.51–2.58) 
1.1 (0.17–7.32)/1.3 (0.54–
2.92) 
0.27/0.74 0.91/0.59 
≥75 (963/904) 0.9 (0.33–2.33)/0.9 (0.42–
1.89) 
0.9 (0.33–2.30)/0.9 (0.43–
1.99) 
0.79/0.75 0.77/0.84 
 
Table 2. Logistic regressions for association between (Bone Mineral Density)BMD and 
tertiled Telomere Length (TL) (Tang et al., 2010) 
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 In contrast Valdes et al. (Valdes et al., 2007) reported that follow adjustments for multiple 
variants,  BMD was correlated with Telomere Length. In addition, women with osteoporosis 
have shorter Telomere Lengths. Following their observation of negative correlation between 
Telomere Length and age and the association with bone loss, Bekaert et al. concluded that 
Telomere Length can serve as a predictor for bone loss (Bekaert et al., 2005).  Kveiborg et al. 
took this comparison a step further and showed increased telomere attrition with age in 
cultured aging osteoblasts cells. However, this pattern was not observed in a groups of 
osteoporotic women and age matched elderly cohort, dismissing the notion that cell 
senescense occur much earlier in osteoporotic patients (Kveiborg et al., 1999). 
Terc(-/-) mice (abolished telomerase activity) have been used to explore the mechanism 
behind telomere shortening in vivo and its association with bone loss. One of the 
phenotypes of this strain of mice is that they demonstrate accelerated rate of bone loss with 
age (Saeed et al., 2011). In cultured bone cells isolated from these mice, impaired osteogenic 
differentiation and reduced proliferation as well as accelerate senescence and DNA damage 
have been observed (Saeed et al., 2011). In addition, overexpression of proinflammatory 
genes involved in osteoclast differentiation was demonstrated by microarray screening. 
Thus, two mechanisms associate with bone deterioration with age have been demonstrated 
in telomerase deficient mice, suggesting presence of such a mechanism with aging: A) Bone 
cells damage and, B) Over expression of proinflammatory genes (Saeed et al., 2011). Similar 
observation of low bone mass phenotype and age-related osteoporosis has been reported in 
double knockout mice (the telomerase deficient and Wrn helicase which caused premature 
aging). In addition, mesenchymal stem cells (MSCs) from the double knockout mice have a 
short lifespan and impaired osteogenic in vitro (Pignolo et al., 2008). 
2.4 Telomere and epigenetic 
Chronological aging is a risk for numerous chronic diseases such as cardiovascular disease 
and type 2 diabetes mellitus (Resnick et al., 2000; Najjar et al., 2005) that affect the quality of 
life and lifespan. Epigenetics (acquired or heritable changes in gene function or phenotypes 
without changes in DNA sequence), has emerged as an important factor in gene expression 
and disease risk. Epigenetics refer to several mechanisms by which gene expression, DNA 
replication, DNA damage repair, and DNA recombination are modulated. In this section, 
we will review the advances in the research of epigenetics of aging and its relevance to 
Telomere Length. 
Response of fetus to environmental stressors such as poor nutrition resulted in the early 
occurrence of age-associated diseases later in life (Barker Hypothesis). Such hypothesis was 
supported by animal models of IUGR (intra uterine growth restriction): these animals 
develop age-associated diseases significantly earlier than their normal birth cohorts. This 
observation was supported by growing evidence for the involvement of DNA methylation 
and histone modifications in gene expression during gestation, an effect leading to 
permanent cell damage and shorter Telomere Length (Barnes & Ozanne 2011). 
A relationship between folate (precursors for nucleotide synthesis modulated by DNA 
methylation) and Telomere Length was proposed by Paul et al. Among a middle age and 
elderly cohort, subjects with higher folate plasma concentration had longer telomeres (Paul 
et al., 2009). Kim et al. proposed that artificial increase of folate in the diet can increase 
Telomere Length and telomerase activity, thus promoting healthy aging (Kim et al., 2009). 
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From a more mechanistic view, Gonzalez-Suarez & Gonzalo suggested that since aging is 
associated with increased chromatin defects as a result of alteration in processes associated 
with nuclear organization, an involvement of epigenetics in telomeric and subtelomeric 
region is crucial to decelerating cell senescence and therefore healthy aging. (Gonzalez-
Suarez & Gonzalo 2008). Blasco report subtelomeric regions that are affected by histone 
modification of methyltransferases and DNA methyltransferases providing evidence for 
epigenetic regulation of telomere-length (Blasco 2007). 
Another interestingly popular view was presented by Zeng, who hypothesized that the 
differentiation of undifferentiated Human Embryonic Stem Cells (hESCs) into somatic cell 
transforms them from immortal to mortal cells. Since the Telomere Length was maintained 
by active telomerase in the hESCs, transition to mortal cells results in loss of this 
maintenance and over time, will lead to cell death. Such a transition, the author argues, is 
modulated by epigenetic changes as the aging environment is changed. Controlling this 
environment by understanding the genomic and epigenetic of the immortal hESC can lead 
to successful control of somatic cell senescence and thus could offer a better treatment for 
age associated diseases (Zeng 2007). Tam et al. elaborated on this strategy and suggested 
reprogramming those cells by various techniques such as cell fusion, somatic cell nuclear 
transfer and more. Employing gene expression alteration or changing chromatin epigenetic 
state reverses the cellular ageing by controlling both Telomere Length and telomerase 
activity (Tam et al., 2007). Fraga et al. indicated a global perspective on hypomethylation and 
CpG island hypermethylation changes during aging to have their impact on cell senescence 
through the effect on telomere attrition and telomerase activity (Fraga et al., 2007). Thus, 
epigenetic regulation of Telomere Length is an extremely complex but potentially 
interesting avenue that could lead to modifications of disease risk and healthy aging. 
2.5 Telomere and longevity 
Extremely long life span or in its more common term “Longevity” is a result of multiple 
variables including genetic, epigenetic and environmental factors. Longevity, the right tail of 
life expectancy (increases steadily by quarter of a year every year (Oeppen & Vaupel 2002)) 
is more prevalent now due to improvements in not only medical treatment and knowledge, 
but also access to better nutrition, food availability, healthy environment, and overall self 
secure. Human longevity can be reached in many ways such as having a favourable genetic 
background (Schumacher et al., 2009), a low degree of disability (Terry et al., 2008), robust 
maintenance of physiological functions (Barzilai et al., 2010), diet (Hausman et al., 2011), 
front of the line healthcare (Michaud et al., 2011), environment (de Magalhaes et al., 2012),  
and cellular and DNA maintenance (Schumacher et al., 2009; Barzilai 2010). Can long 
Telomere Length be considered as one? 
Telomere Length may play a role in the genetics of human longevity (Guan et al., 2007). The 
question is how and where? Guan et al. investigate this question among a wide range of 
aged people. They report decreased mean Telomere Length with age; a trend that was less 
steep among women (Guan et al., 2007). Friedrich et al. expanded their study to more 
advanced ages with three different sources of telomeres from the same donor. Interestingly, 
leukocytes demonstrated significantly shorter telomere compared to skin and synovial 
tissues within donors. In addition, the leucocyte and skin sources exhibit significant attrition 
with age, suggesting leukocytes as a surrogate indicator for Telomere Length for other 
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tissues (Friedrich et al., 2000).  Stindl reported similar results for both negative correlation 
between mean Telomere Length and longevity and shorter telomeres among men. Stindl 
attributes these sex differences to different body size and propose that increased height 
differences are the main reason why women outlive men in the western countries (Stindl 
2004). Manestar-Blazic took a step backwards and suggests that Telomere Length and 
longevity depend on the telomere state in the germ line of the parents at conception. 
Telomere Length in the gametes of the parents is a yin-yang situation; the longer they are, 
the faster they attrite, the best composition between the two opposing mechanism will 
define the starting point for the offspring Telomere Length and thus their longevity 
(Manestar-Blazic 2004). This is supported by Njajou et al., who studied a large cohort of the 
Amish. Telomere Length was negatively associated with aging, was not different between 
genders and positively correlated with paternal lifespan when offspring and their parents 
were tested, suggesting a positive influence of Telomere Length and cross generation 
lifespan (Njajou et al., 2007). In a different view, Bakaysa et al. established Telomere Length 
as a biomarker for survival on Swedish twins excluding environmental and familial effects. 
In their study, subjects with shorter telomeres have shorter survival compared to his/her 
twin sibling with longer telomeres (Bakaysa et al., 2007). Kimura et al. demonstrated the 
same in the oldest old; a decline of overall mean Telomere Length with age and difference 
between genders with females having longer mean Telomere Length compared to men. 
Interestingly enough, the average shorter telomere observed in the oldest old could be due 
to a higher percentage of short telomere fragments compared to young age subjects (Kimura 
et al., 2007). Further support for this phenomenon has been observed in gray and white 
matter autopsy samples from 72 subjects aged 0-100 YO. The authors reported of a decline 
in mean Telomere Length until the age of 79  followed by an increase in Telomere Length 
with age in the higher age group (Nakamura et al., 2007).   
On the other hand multiple studies have reported a lack of association between Telomere 
Length and longevity. Njajou et al., using leukocyte from peripheral blood from a large 
cohort of mixed ethnicity, found no association for either survival or early death from major 
age associated disease. However, Telomere Length was linked to healthy aging suggesting 
that Telomere Length may be an indirect biomarker for longevity (Njajou et al., 2009). 
Graakjaer et al. used different technology to measure Telomere Length by fluorescent in situ 
hybridization (FISH) and report unique length distribution within individuals (on the cell 
level) and between individuals. Interestingly enough, this unique Telomere Length 
distribution doesn't change much through life and is partially inherited, suggesting a lesser 
involvement of Telomere Length with longevity and more as an accompanied trait 
(Graakjaer et al., 2006). 
Searching for the secret of long-lived life of extremely old individuals, Terry et al. studied 
centenarians. Telomere Length was significantly longer in the healthy group compared to 
the unwell centenarians, suggesting health as a major component of telomere maintenance 
and not necessarily longevity mechanism. Terry et al. concluded that survival to old age is 
not a factor of Telomere Length rather than a signature for healthy performance (Terry et al., 
2008). Taking extended centenarian cohort, we found that centenarian and their offspring 
exhibit longer telomeres compared to controls. Since this phenomenon was across the board 
including healthy and non healthy centenarians, we suggested Telomere Length as a 
longevity associated trait especially since the offspring of centenarians (inherited at least 
half of the genetic background of their extremely performed parents) demonstrate the same 
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trend. We attributed this observation to slow attrition rate, suggesting higher telomere 
maintenance among families with longevity (figure 7) (Atzmon et al., 2010). Same 
observation was reported by Ishikawa et al.. Cross sectional (0 and 100 years) measurement 
of Telomere Length in normal pituitary glands revealed decline in Telomere Length with 
age until certain point where the trend of Telomere Length attrition reversed and show 
longer telomere among the oldest old (Ishikawa et al., 2011). Such observation points to the 
fact that different mechanism of telomere maintenance exists in the extremely old people. 
This also suggests that observation of longer Telomere Length compared to age-matched 
controls in a cross-sectional assessment early in life could be a surrogate indicator for 
longevity. 
 
Fig. 7. Comparison of Telomere Length among Ashkenazi Jewish centenarians (n = 86), their 
offspring (n = 175), and controls (n = 93). Values are adjusted for age at recruitment and 
gender in the offspring and control groups and for gender alone in the centenarian group *P 
< 0.05. (Atzmon et al., 2010) 
3. Telomere maintenance mechanisms 
One of the critical mechanisms by which telomere is maintained, is through the enzyme 
telomerase reverse transcriptase (TERT) activity. Telomerase is the enzyme that is 
responsible for the elongation of the telomere, an action that reverses the telomere attrition. 
Higher telomerase activity would increase Telomere Length and extend cell proliferation 
potential, while lower activity would result in shorter telomere (Nicholls et al., 2011).    
Using telomerase-deficient mice, Jaskelioff et al. demonstrated the crucial role of Telomere 
Length in cell senescence. Under conditional mutation, the mice that lack telomerase activity 
developed age associated phenotypes including shorter telomeres and increased DNA 
damage. Reactivation of the telomerase activity reversed the aging phenotypes and restored 
Telomere Length that in turn led to less DNA damage. This elegant study reemphasized the 
importance of Telomere Length and its maintenance by the telomerase activity for cell 
proliferation and longevity, supporting the notion of telomerase as longevity precursor 
(Jaskelioff et al., 2011) 
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The importance of telomerase activity in telomere maintenance and cell senescence was 
demonstrated by introducing an alternative strategy for telomere maintenance (ALT) (Wu et 
al.). This strategy is executed in telomerase deficient cells in order to preserve cell growth 
and maintain the balance between cell senescence and tumorigenesis. However, this 
introduced substantial Telomere Length variability, and therefore more complexity (Wu et 
al., 2009). Royle et al. expanded the ALT mechanism by including processes that are 
activated in the absence of telomerase activity such as telomere chromatid exchange 
elevation, blocking t-loops and activation of recombination-based processes that restore 
replication capability (Royle et al., 2009). Cell proliferation has been crafted through 
evolution to the point that each system is in harmony with its environment; hence any 
changes in this balance (although there are alternatives) will have deleterious impact. Pessos 
et al. suggested telomere attrition as the cause for cellular senescence, a mechanism that is 
similar to tumor suppressing. However, evidence exists for involvement of multiple 
processes in cell senescence such as mitochondrial function, ROS, chromatin, and functional 
and biochemical complexes (Passos et al., 2009). An alternative view of the impact of stress 
on Telomere Length was reviewed by Epel et al. They proposed a model of two opposing 
systems to demonstrate the effect of psychological function on Telomere Length; a. stress 
condition which increases cortisol, insulin and oxidative stress, all of which shorten 
telomere and lower telomerase activity;  and b. positive cognition which increases androgen, 
GH axis activity and vagal tone and therefore telomere maintenance (figure 8) (Epel et al., 
2009). Involvement of sex hormones in telomere maintenance and telomerase activity were 
further elucidated by Li et al.. Reviewing the role of estrogen in cell proliferation, Li et al. 
suggested mechanisms by which estrogen regulates the telomerase activity and therefore 
Telomere Length (Li et al., 2010). Since estrogen declines with age, its role as telomere 
homeostasis regulator are limited, thus other mechanisms are introduced to compensate for 
its absence (Li et al., 2010). On the protein level, The RecQ helicases (mainly WRN and BLM) 
were introduced by Bohr, as a protein family that is responsible for telomere maintenance,  
and defects in these proteins are associated with poor telomere maintenance and early 
aging. Interaction of the main proteins (i.e. WRN and BLM) with the telomere region 
exposes DNA damage and activates damage responses. The various mechanisms by which  
 
Fig. 8. Effects of Mindfulness Meditation on Telomere Length through Positive and Stressful 
Cognitive States. The dotted arrows represent inverse relationships specifically, we propose 
that positive arousal promotes and stress arousal prevents telomere maintenance (Epel et al., 
2009) 
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RecQ helicases offer genome and specifically telomere maintenance can provide us with a 
clue towards successful aging (Bohr 2008). Stem cell research offers another interesting point 
of view. This source for cell renewal functionality declines with age; the same process was 
observed in telomerase deficient mice (Song et al., 2009). This connection has been further 
strengthened by demonstration of over expression of 4 genome maintenance proteins in 
plasma during aging in humans. Furthermore, this has been demonstrated in older people 
with age associated diseases suggesting that provocation of the DNA damage machinery 
interacts closely with telomere dysfunction status (Jiang et al., 2008). 
4. Telomere Length in the genomic era 
Candidate gene approach has been a major source in the revelation of the underline genetic 
mechanisms involved in telomerase activity and telomere maintenance. However, these 
discoveries were loci dependent, providing explanation very specifically on the immediate 
genetic components affecting telomerase activity and Telomere Length. Recent advances in 
genomic tools provide us with a more global view as well as network interaction on the 
genetic basis of telomerase activity and Telomere Length. From this perspective, Codd et al. 
conducted GWAS with mean leukocyte Telomere Length and demonstrate an area near the 
TERC locus that is significantly associated with mean Leukocyte Telomere Length (Codd et al., 
2010). Similar analysis has been performed in a consortium of four Caucasian cohorts. In this 
study, the strength of the unbiased screening revealed new genes associated with Leukocyte 
Telomere Length such as OBFC1 and the cytokine CXCR4 as well as the TERC, demonstrating 
multi-component genetic effects on Telomere Length that could only have been discovered 
through unbiased genomic screening (Levy et al., 2010).  Gu et al. conducted a multistage 
GWAS and found a locus next to a gene that involves in cytokine production PELI2 that is 
significantly associated with Leukocyte Telomere Length, thus increasing the palette of 
possible genes associated with  Leukocyte Telomere Length (Gu et al., 2011). Prescott et al. 
replicated previously identified GWAS loci TERC in the Nurses' Health Study but failed to 
replicate other locus or identify any new loci significant associated with Telomere Length 
(Prescott et al., 2011). Shen et al., not surprisingly detected the TERC locus to have significant 
effect on Leukocyte Telomere Length in Chinese population through unbiased genome 
screening (Shen et al., 2011); the same two SNPs were found to be associated with Telomere 
Length as well as longevity in the oldest-old Danes (Soerensen et al., 2011). 
Although there is evidence for association with Telomere Length in multiple facets of aging 
and age-related diseases, neither a conclusive causative link nor a predictable association 
has been established. Thus, the main question whether Telomere Length drives the aging 
process or is influenced by aging or age-associated diseases remains unresolved. Advance in 
technologies in genomics, more studies using animal models and human cells as well as 
improved understanding of telomere maintenance will help us answer this question 
unequivocally leading to the use of Telomere Length as a biomarker and ultimately 
personalized medicine. 
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